Valuation: LifeVantage Corporation

Market Cap 82.38M 72.36M 67.29M 61.75M 116M 7.93B 118M 799M 312M 3.9B 309M 303M 13.49B P/E 2026 *
15.5x
P/E 2027 * 16.7x
Enterprise Value 68.83M 60.45M 56.22M 51.59M 96.93M 6.63B 98.43M 668M 261M 3.26B 258M 253M 11.27B EV / Sales 2026 *
0.37x
EV / Sales 2027 * 0.38x
Free-Float
87.97%
Yield 2026 *
-
Yield 2027 * -
1 day+4.15%
1 week+5.32%
Current month+4.65%
1 month-1.36%
3 months+28.54%
6 months+11.43%
Current year+6.01%
1 week 6.18
Extreme 6.18
6.61
1 month 5.82
Extreme 5.82
6.68
Current year 3.9
Extreme 3.9
11.71
1 year 3.9
Extreme 3.9
15
3 years 3.9
Extreme 3.9
27.38
5 years 3.04
Extreme 3.04
27.38
10 years 2.86
Extreme 2.86
27.38
Manager TitleAgeSince
Chief Executive Officer 74 30/04/2026
Director of Finance/CFO 53 25/10/2021
Chief Tech/Sci/R&D Officer - 07/01/2026
Director TitleAgeSince
Director/Board Member 74 01/01/2012
Director/Board Member 67 01/02/2017
Director/Board Member 68 17/02/2022
Date Insider Type Main position Quantity % Market Cap.
01/07/26 Tax

General Counsel

-1,342 0.0106%
01/07/26 Tax

Chief Financial Officer

-1,361 0.0108%
01/07/26 Tax

Responsable ventes & marketing

-1,717 0.0136%
Change 5-day change 1-year change 3-year change Capi.($)
+4.15%+5.32%-52.37%+26.80% 82.38M
+0.86%+1.43%+47.17%+163.68% 1,067B
+1.59%+4.09%+56.51%+52.50% 635B
+0.95%+1.91%+36.30%+82.78% 458B
+1.60%+6.25%+37.00%+31.03% 347B
-0.60%+1.52%+36.67%+41.41% 295B
-0.14%+0.60%+17.29%+18.74% 262B
+0.09%-2.82%-29.09%-39.57% 216B
+1.22%+2.66%+22.66%+59.87% 203B
-1.18%-3.70%+11.28%+67.52% 161B
Average +0.85%+1.73%+18.34%+50.48% 364.36B
Weighted average by Cap. +0.76%+1.95%+35.99%+79.10%

Financials

2026 *2027 *
Net sales 184M 162M 150M 138M 259M 17.74B 263M 1.79B 698M 8.72B 691M 677M 30.15B 178M 157M 146M 134M 251M 17.18B 255M 1.73B 676M 8.44B 670M 655M 29.2B
Net income 5.3M 4.65M 4.33M 3.97M 7.46M 510M 7.58M 51.41M 20.08M 251M 19.9M 19.47M 868M 4.9M 4.3M 4M 3.67M 6.9M 472M 7.01M 47.53M 18.57M 232M 18.39M 18M 802M
Net Debt -13.55M -11.9M -11.07M -10.16M -19.08M -1.3B -19.38M -131M -51.35M -642M -50.87M -49.77M -2.22B -15M -13.17M -12.25M -11.24M -21.12M -1.44B -21.44M -145M -56.82M -710M -56.29M -55.08M -2.45B
Logo LifeVantage Corporation
LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
Employees
235
Date Price Change Volume
24/07/26 $6.530 +4.15% 57,611
23/07/26 $6.270 -1.26% 63,938
22/07/26 $6.350 -0.78% 83,616
21/07/26 $6.400 +2.24% 72,319
20/07/26 $6.260 +0.97% 60,598
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.530USD
Average target price
7.000USD
Spread / Average Target
+7.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LFVN Stock